All In MedTech

Device Trial Radar · NCT06231511

Soft Exosuits for Functional Gait Recovery in Acute Stroke Rehabilitation

Last checked: Nov 20, 2026Latest source record: Aug 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

26

Actual

Start

Jul 30, 2021

Primary completion

Apr 15, 2024

Study completion Apr 15, 2024

Sponsor

Lead sponsor
Shirley Ryan AbilityLabAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Harvard University
First posted
Jan 30, 2024

More device trials from this sponsor

Design

Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to develop and evaluate the use of soft exosuits in patients post stroke.

Conditions

  • Stroke
  • Acute Stroke

Interventions

  • Hip flexion soft exosuitDevice

    Participants will utilize a Wyss designed hip flexion soft exosuit. This device has a small rope winch at the front of the hip connected to a functional textile waistband and thigh band. It applies an assistive torque in response to wearable sensor measurements.

  • ReWalk ReStore soft exosuitDevice

    Participants will utilize the ReWalk ReStore ankle soft exosuit. This device provides dynamic plantarflexion and dorsiflexion during walking intended to restore paretic limb function resulting in improved gait symmetry, reduced energy cost of walking and improved stability. The exosuits consists of a body-worn actuation unit containing motors, gears, and pulleys that when powered generate forces that are transmitted via Bowden cables to functional textiles anchored proximal and distal to a joint. This actuation occurs in response to signals from embedded wearable sensors.

  • Conventional physical therapyOther

    Participants will complete conventional physical therapy without use of exosuits during the course of their inpatient rehabilitation stay.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in 10 Meter Walk TestTime frame: Admission time-point to discharge time-point (estimated 2-4 weeks). Pre-assessment completed after admission to inpatient rehabilitation, prior to first intervention session. Post-assessment completed following last treatment session, prior to discharge.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shirley Ryan AbilityLab

    Chicago, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.